The DNA-PK Inhibitor VX-984 Enhances the Radiosensitivity of Glioblastoma Cells Grown In Vitro and as Orthotopic Xenografts

Molecular Cancer Therapeutics - Tập 17 Số 6 - Trang 1207-1216 - 2018
Cindy R. Timme1, Barbara H. Rath1, John W. O'Neill1, Kevin Camphausen1, Philip J. Tofilon1
1Radiation Oncology Branch, National Cancer Institute, Bethesda, Maryland.

Tóm tắt

Abstract Radiotherapy is a primary treatment modality for glioblastomas (GBM). Because DNA-PKcs is a critical factor in the repair of radiation-induced double strand breaks (DSB), this study evaluated the potential of VX-984, a new DNA-PKcs inhibitor, to enhance the radiosensitivity of GBM cells. Treatment of the established GBM cell line U251 and the GBM stem-like cell (GSC) line NSC11 with VX-984 under in vitro conditions resulted in a concentration-dependent inhibition of radiation-induced DNA-PKcs phosphorylation. In a similar concentration-dependent manner, VX-984 treatment enhanced the radiosensitivity of each GBM cell line as defined by clonogenic analysis. As determined by γH2AX expression and neutral comet analyses, VX-984 inhibited the repair of radiation-induced DNA double-strand break in U251 and NSC11 GBM cells, suggesting that the VX-984-induced radiosensitization is mediated by an inhibition of DNA repair. Extending these results to an in vivo model, treatment of mice with VX-984 inhibited radiation-induced DNA-PKcs phosphorylation in orthotopic brain tumor xenografts, indicating that this compound crosses the blood–brain tumor barrier at sufficient concentrations. For mice bearing U251 or NSC11 brain tumors, VX-984 treatment alone had no significant effect on overall survival; radiation alone increased survival. The survival of mice receiving the combination protocol was significantly increased as compared with control and as compared with radiation alone. These results indicate that VX-984 enhances the radiosensitivity of brain tumor xenografts and suggest that it may be of benefit in the therapeutic management of GBM. Mol Cancer Ther; 17(6); 1207–16. ©2018 AACR.

Từ khóa


Tài liệu tham khảo

Stupp, 2005, Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma, N Engl J Med, 352, 987, 10.1056/NEJMoa043330

De Bonis, 2013, The influence of surgery on recurrence pattern of glioblastoma, Clin Neurol Neurosurg, 115, 37, 10.1016/j.clineuro.2012.04.005

Rapp, 2017, Recurrence pattern analysis of primary glioblastoma, World Neurosurg, 103, 733, 10.1016/j.wneu.2017.04.053

Davis, 2014, DNA-PK: a dynamic enzyme in a versatile DSB repair pathway, DNA Repair (Amst), 17, 21, 10.1016/j.dnarep.2014.02.020

Smith, 1999, The DNA-dependent protein kinase, Genes Dev, 13, 916, 10.1101/gad.13.8.916

Lees-Miller, 1995, Absence of p350 subunit of DNA-activated protein kinase from a radiosensitive human cell line, Science, 267, 1183, 10.1126/science.7855602

Hoppe, 2000, Complementation of the radiosensitive M059J cell line, Radiat Res, 153, 125, 10.1667/0033-7587(2000)153[0125:COTRMC]2.0.CO;2

Tavecchio, 2012, Further characterisation of the cellular activity of the DNA-PK inhibitor, NU7441, reveals potential cross-talk with homologous recombination, Cancer Chemother Pharmacol, 69, 155, 10.1007/s00280-011-1662-4

Liu, 2015, DNA-PKcs deficiency inhibits glioblastoma cell-derived angiogenesis after ionizing radiation, J Cell Physiol, 230, 1094, 10.1002/jcp.24841

Pospisilova, 2017, Small molecule inhibitors of DNA-PK for tumor sensitization to anticancer therapy, J Physiol Pharmacol, 68, 337

Zhou, 2017, Targeting glioma stem cell-derived pericytes disrupts the blood–tumor barrier and improves chemotherapeutic efficacy, Cell Stem Cell, 21, 591, 10.1016/j.stem.2017.10.002

van Tellingen, 2015, Overcoming the blood–brain tumor barrier for effective glioblastoma treatment, Drug Resist Updat, 19, 1, 10.1016/j.drup.2015.02.002

Harnor, 2017, Targeting DNA-dependent protein kinase for cancer therapy, ChemMedChem, 12, 895, 10.1002/cmdc.201700143

Singh, 2004, Identification of human brain tumour initiating cells, Nature, 432, 396, 10.1038/nature03128

McCord, 2009, CD133+ glioblastoma stem-like cells are radiosensitive with a defective DNA damage response compared with established cell lines, Clin Cancer Res, 15, 5145, 10.1158/1078-0432.CCR-09-0263

Pollard, 2009, Glioma stem cell lines expanded in adherent culture have tumor-specific phenotypes and are suitable for chemical and genetic screens, Cell Stem Cell, 4, 568, 10.1016/j.stem.2009.03.014

Rath, 2013, Astrocytes enhance the invasion potential of glioblastoma stem-like cells, PLoS One, 8, e54752, 10.1371/journal.pone.0054752

Collins, 2004, The comet assay for DNA damage and repair: principles, applications, and limitations, Mol Biotechnol, 26, 249, 10.1385/MB:26:3:249

Jamal, 2012, The brain microenvironment preferentially enhances the radioresistance of CD133(+) glioblastoma stem-like cells, Neoplasia, 14, 150, 10.1593/neo.111794

Chen, 2005, Cell cycle dependence of DNA-dependent protein kinase phosphorylation in response to DNA double strand breaks, J Biol Chem, 280, 14709, 10.1074/jbc.M408827200

Mah, 2010, gammaH2AX: a sensitive molecular marker of DNA damage and repair, Leukemia, 24, 679, 10.1038/leu.2010.6

Milano, 2010, Patterns and timing of recurrence after temozolomide-based chemoradiation for glioblastoma, Int J Radiat Oncol Biol Phys, 78, 1147, 10.1016/j.ijrobp.2009.09.018

Takata, 1998, Homologous recombination and non-homologous end-joining pathways of DNA double-strand break repair have overlapping roles in the maintenance of chromosomal integrity in vertebrate cells, EMBO J, 17, 5497, 10.1093/emboj/17.18.5497

Valerie, 2003, Regulation and mechanisms of mammalian double-strand break repair, Oncogene, 22, 5792, 10.1038/sj.onc.1206679

An, 2008, DNA-dependent protein kinase catalytic subunit modulates the stability of c-Myc oncoprotein, Mol Cancer, 7, 32, 10.1186/1476-4598-7-32

Tang, 2014, Repair of radiation damage of U2OS osteosarcoma cells is related to DNA-dependent protein kinase catalytic subunit (DNA-PKcs) activity, Mol Cell Biochem, 390, 51, 10.1007/s11010-013-1955-5

Gustafsson, 2014, Suppression of DNA-dependent protein kinase sensitize cells to radiation without affecting DSB repair, Mutat Res, 769, 1, 10.1016/j.mrfmmm.2014.06.004

Nagasawa, 2011, Differential role of DNA-PKcs phosphorylations and kinase activity in radiosensitivity and chromosomal instability, Radiat Res, 175, 83, 10.1667/RR2092.1

Willmore, 2008, DNA-dependent protein kinase is a therapeutic target and an indicator of poor prognosis in B-cell chronic lymphocytic leukemia, Clin Cancer Res, 14, 3984, 10.1158/1078-0432.CCR-07-5158

Abdel-Fatah, 2014, ATM, ATR and DNA-PKcs expressions correlate to adverse clinical outcomes in epithelial ovarian cancers, BBA Clin, 2, 10, 10.1016/j.bbacli.2014.08.001

Cornell, 2015, DNA-PK-A candidate driver of hepatocarcinogenesis and tissue biomarker that predicts response to treatment and survival, Clin Cancer Res, 21, 925, 10.1158/1078-0432.CCR-14-0842

Dolman, 2015, DNA-dependent protein kinase as molecular target for radiosensitization of neuroblastoma cells, PLoS One, 10, e0145744, 10.1371/journal.pone.0145744

Bouchaert, 2012, DNA-PKcs expression predicts response to radiotherapy in prostate cancer, Int J Radiat Oncol Biol Phys, 84, 1179, 10.1016/j.ijrobp.2012.02.014

Goodwin, 2015, DNA-PKcs-mediated transcriptional regulation drives prostate cancer progression and metastasis, Cancer Cell, 28, 97, 10.1016/j.ccell.2015.06.004

Kase, 2011, Impact of PARP-1 and DNA-PK expression on survival in patients with glioblastoma multiforme, Radiother Oncol, 101, 127, 10.1016/j.radonc.2011.06.024

Tichy, 2012, Radio-sensitization of human leukaemic molt-4 cells by DNA-dependent protein kinase inhibitor, NU7026, Acta Medica (Hradec Kralove), 55, 66, 10.14712/18059694.2015.57

Zhao, 2006, Preclinical evaluation of a potent novel DNA-dependent protein kinase inhibitor NU7441, Cancer Res, 66, 5354, 10.1158/0008-5472.CAN-05-4275

Ciszewski, 2014, DNA-PK inhibition by NU7441 sensitizes breast cancer cells to ionizing radiation and doxorubicin, Breast Cancer Res Treat, 143, 47, 10.1007/s10549-013-2785-6

Quiros, 2011, Rad51 and BRCA2–New molecular targets for sensitizing glioma cells to alkylating anticancer drugs, PLoS One, 6, e27183, 10.1371/journal.pone.0027183

Shaheen, 2011, Targeting the DNA double strand break repair machinery in prostate cancer, PLoS One, 6, e20311, 10.1371/journal.pone.0020311

Dong, 2017, Inhibiting DNA-PKcs in a non-homologous end-joining pathway in response to DNA double-strand breaks, Oncotarget, 8, 22662, 10.18632/oncotarget.15153

Hayat, 2015, Brain Metastases from Primary Tumors, vol. 2: Epidemiology, Biology, and Therapy

Thông tin
Thông tin xuất bản

Molecular Cancer Therapeutics

Tập 17 Số 6

1207-1216

Thông tin tác giả